120 related articles for article (PubMed ID: 8512763)
1. Inhibition of angiotensin converting enzyme with enalapril maleate in infants with congestive heart failure.
Dutertre JP; Billaud EM; Autret E; Chantepie A; Oliver I; Laugier J
Br J Clin Pharmacol; 1993 May; 35(5):528-30. PubMed ID: 8512763
[TBL] [Abstract][Full Text] [Related]
2. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
Luzier AB; Forrest A; Adelman M; Hawari FI; Schentag JJ; Izzo JL
Am J Cardiol; 1998 Aug; 82(4):465-9. PubMed ID: 9723634
[TBL] [Abstract][Full Text] [Related]
3. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
[TBL] [Abstract][Full Text] [Related]
5. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
6. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
MacFadyen RJ; Lees KR; Reid JL
Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
[TBL] [Abstract][Full Text] [Related]
7. Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure.
Qiu CB; Qiu CS; Hess P; Clozel JP; Clozel M
Acta Pharmacol Sin; 2001 Jun; 22(6):541-8. PubMed ID: 11747762
[TBL] [Abstract][Full Text] [Related]
8. Enalapril: a long-acting angiotensin-converting enzyme inhibitor.
Borek M; Charlap S; Frishman W
Pharmacotherapy; 1987; 7(5):133-48. PubMed ID: 2829141
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitor (enalapril maleate) accelerates recovery of mouse skin from UVB-induced wrinkles.
Matsuura-Hachiya Y; Arai KY; Ozeki R; Kikuta A; Nishiyama T
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):38-43. PubMed ID: 24216112
[TBL] [Abstract][Full Text] [Related]
10. [Vasodilator hormonal agents in chronic heart failure: effect of angiotensin-converting enzyme inhibitors].
Godoy I; Corbalán R; Jalil J; Guarda E; Albertini R
Rev Med Chil; 1997 Feb; 125(2):135-42. PubMed ID: 9430932
[TBL] [Abstract][Full Text] [Related]
11. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
Edling O; Bao G; Feelisch M; Unger T; Gohlke P
J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
Guazzi M; Melzi G; Marenzi GC; Agostoni P
Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
[TBL] [Abstract][Full Text] [Related]
15. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
Lantis AC; Ames MK; Werre S; Atkins CE
J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
[TBL] [Abstract][Full Text] [Related]
17. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors in congestive heart failure.
Deedwania PC
Arch Intern Med; 1990 Sep; 150(9):1798-805. PubMed ID: 2132302
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacogenomic control of angiotensin converting enzyme gene I/D polymorphism predominant risk factor of development of chronic heart failure and target of enalapril treatment].
Tepliakov AT; Shilov SN; Berezikova EN; Efremov AV; Safronov ID; Pustovetova MG; Maianskaia SD; Torim IuIu; Karpov RS
Kardiologiia; 2013; 53(3):9-14. PubMed ID: 23548421
[TBL] [Abstract][Full Text] [Related]
20. Treatment with angiotensin-converting-enzyme inhibitor for epirubicin-induced dilated cardiomyopathy.
Jensen BV; Nielsen SL; Skovsgaard T
Lancet; 1996 Feb; 347(8997):297-9. PubMed ID: 8569365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]